Guardant Health Inc. (NASDAQ:GH) is one of the best mid cap pharma stocks to buy. On July 15, Guardant Health announced the ...

Scientists at Johns Hopkins University found that a blood test could detect cancer DNA more than three years before a patient receives a clinical diagnosis. The study, published in May in the journal ...

A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, noninvasive ...

Mean corpuscular hemoglobin is the average amount of hemoglobin per blood cell, and it is measured with a blood test. This value can help diagnose anemia and other diseases.

The lumipulse blood test brings renewed hope for earlier diagnosis and treatment for millions of people facing the uncertainty of Alzheimer's disease and other dementias.

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other medical conditions that can cause cognitive difficulties.

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s disease, the first diagnostic tool that uses a blood draw to check for ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline.

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.